P&G WINS OK TO MARKET BONE DRUG.(NEWS) - Cincinnati Post - HighBeam Research (Subscription)
$4.95 - PR Newswire - ECNext - Jun 19, 2003 In a long-term clinical trial of Actonel(R) (risedronate sodium tablets), a low incidence of new vertebral fractures was maintained over 7 years of ..
|